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PCR primers targeting loci in the current Burkholderia cepacia complex multilocus sequence typing scheme
were redesigned to (i) more reliably amplify these loci from B. cepacia complex species, (ii) amplify these same
loci from additional Burkholderia species, and (iii) enable the use of a single primer set per locus for both
amplification and DNA sequencing.
The multilocus sequence typing (MLST) scheme for the
Burkholderia cepacia complex has provided important insights
into the population dynamics, diversity, and recombination
events in this group of opportunistic pathogens (1–3, 7). It has
also been effective in identifying previously misclassified strains
and has proved useful in the recent identification of seven
novel species in the B. cepacia complex (9, 10). This expansion
of the B. cepacia complex and our growing appreciation that
other Burkholderia species, particularly B. gladioli, are also
involved in human infection, provide an opportunity to expand
the capacity of the current MLST scheme. We thus sought to
redesign the primers targeting the loci in the current MLST
scheme to (i) more reliably amplify these seven loci from all 17
B. cepacia complex species; (ii) amplify these loci from addi-
tional Burkholderia species, including B. gladioli and as yet
unclassified Burkholderia species; and (iii) enable the use of a
single primer set per locus for both amplification and DNA
sequencing.
We aligned all seven loci (atpD, gltB, gyrB, lepA, phaC, recA,
and trpB) in the current MLST scheme from Burkholderia
strains for which complete genome sequences were available in
the National Center for Biotechnology Information (http:
//www.ncbi.nlm.nih.gov/genomes/lproks.cgi) or Joint Genome
Institute (http://www.jgi.doe.gov/genome-projects/) database.
These strains included Burkholderia ambifaria AMMD, B.
cenocepacia J2315, B. cenocepacia AU1054, B. cenocepacia
PC184, B. multivorans ATCC 17616, B. vietnamiensis G4, B.
dolosa AU0158, B. xenovorans LB400, B. phymatum STM815,
B. phytofirmans PsJN, B. mallei ATCC 23344, Burkholderia sp.
strain 383, and Burkholderia sp. strain H160. Open reading
frames were aligned by using MegAlign (DNASTAR Inc.,
Madison, Wis.), and Burkholderia genus-level primers were
designed to amplify sequences that include the regions ampli-
fied by the original MLST primers (3) (Table 1).
To test the utility and range of the new primers, we per-
formed MLST analysis on strains representing multiple Burk-
holderia species. Strains were obtained from the strain collec-
tions of the Burkholderia cepacia Research Laboratory and
Repository (University of Michigan, Ann Arbor, MI) and
Cardiff University (Cardiff, Wales, United Kingdom). Bacteria
were cultured and lysed as described previously (4). Briefly, a
single bacterial colony was suspended in 20 l of lysis buffer
containing 0.25% (vol/vol) sodium dodecyl sulfate and 0.05 N
NaOH. After the suspension was heated for 15 min at 95°C,
180 l of high-performance liquid chromatography-grade H2O
was added, and the bacterial lysate suspension was stored at
4°C. Amplification of targeted DNA was performed in 25-l
reaction mixture volumes containing a final concentration of 2
mM MgCl2, 20 mM Tris-HCl, 50 mM KCl, 250 M of each
deoxynucleoside triphosphate (ISC Bioexpress, Kaysville, UT),
0.4 M of each primer, 1 M betaine (Sigma-Aldrich, St. Louis,
MO), 10% dimethyl sulfoxide (Sigma-Aldrich), 2 U Taq poly-
merase (Invitrogen, Carlsbad, CA), and 2 l of bacterial lysate.
Amplification was performed with a PTC-100 (MJ Research
Inc., Waltham, MA) thermocycler. After an initial denatur-
ation step of 2 min at 95°C, 30 PCR cycles were completed,
each PCR cycle consisting of 30 s at 94°C, 30 s at the appro-
priate annealing temperature (Table 1), and 60 s at 72°C,
followed by a final extension step of 5 min at 72°C. Sequence
analysis and editing of the amplified DNA were performed as
previously described (8).
Each distinct sequence (allele) at each of the seven loci was
assigned a unique arbitrary number (allele type). For each
allelic profile (considered to be isogenic when they were indis-
tinguishable at all seven loci), a unique arbitrary sequence type
number was assigned. All sequences were deposited in the
Burkholderia cepacia complex MLST database at http:
//pubmlst.org/bcc. Pairwise analysis using Clustal V (DNAStar)
was employed to construct gene trees of the concatenated
sequences of all distinct sequence types.
To confirm that the new primers more reliably amplify
MLST loci from B. cepacia complex strains, we successfully
amplified 43 loci (7 atpD loci, 10 gltB loci, 17 gyrB loci, 2 lepA
loci, 3 phaC loci, 2 recA loci, and 2 trpB loci) from 25 B. cepacia
complex strains that previously had failed to amplify with the
primers and PCR conditions described for the original B.
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cepacia complex MLST scheme (3) (see Table S1 in the sup-
plemental material). To assess the utility of the new primers at
the genus level, we amplified all seven loci from 80 strains
representing 36 named Burkholderia species (including 16 of
the 17 B. cepacia complex species) as well as another 14 Burk-
holderia strains that remain unclassified with respect to species
(see Table S2 in the supplemental material). In all cases, the
new genus-level primer sets provided PCR products of the
expected size that were confirmed as the intended target by
DNA sequence analyses.
The original B. cepacia complex MLST scheme was designed
at a time when the B. cepacia complex was comprised of nine
species and the complete genome sequences of only three B.
cepacia complex strains were available (3). The B. cepacia
complex now includes 17 distinct species, and a total of 68
Burkholderia strains have had or are in the process of having
their genome sequences determined; at least 16 of these strains
represent species within the B. cepacia complex. This expanded
Burkholderia taxonomy and the marked increase in Burkhold-
eria genome sequence information have provided an opportu-
nity to address shortcomings in the original MLST methodol-
ogy. Most problematic is that the original PCR primers fail to
amplify the intended target from a significant minority of B.
cepacia complex strains. Indeed, we have found that approxi-
mately 10% of B. cepacia complex strains analyzed included at
least one locus that could not be amplified by using the original
MLST primers (data not shown). Commonly, such failures
involve strains from the more recently described B. cepacia
complex species; however, loci in strains belonging to the older
B. cepacia complex species (e.g., B. multivorans and B. cenoce-
pacia) have also failed to amplify with these primers. The
original B. cepacia complex MLST method also employed two
sets of oligonucleotide primers per locus: one pair to amplify
the target locus and a second internal nested pair for DNA
sequencing. This approach is advantageous in allowing greater
flexibility in designing sequencing primers when the genetic
diversity of the targeted loci is unclear. However, the greater
Burkholderia genome sequence data now available allowed the
design of a single set of primers for both amplification and
sequencing.
The MLST primers described herein were specifically de-
signed to amplify sequences that include the regions amplified
by the original MLST primers. Therefore, the new primers
provide results that are entirely compatible with the current B.
cepacia complex MLST scheme. These primers were also de-
signed to amplify larger regions (50 bp to 200 bp) of DNA
flanking the loci included in the original MLST scheme. This
allows a single PCR per locus to amplify a region with enough
flanking DNA to provide high-quality sequence read coverage
of the target of interest. The redesigned primers and PCR
conditions also improve the performance of MLST for B.
cepacia complex species; we observed no loci that failed to
amplify with the new primers and PCR conditions, including
several from a set of 25 B. cepacia complex strains that failed
to amplify with the original B. cepacia complex MLST primers.
A potential disadvantage of the new primers and PCR condi-
tions, however, is that since not all loci are amplified with the
same annealing temperatures (Table 1), complete MLST anal-
ysis cannot be performed with a single PCR run.
The use of degenerate primers allowed expansion of the B.
cepacia complex MLST scheme to include analysis of other
Burkholderia species, including the clinically relevant species B.
gladioli, B. mallei, and B. pseudomallei, as well as species im-
portant in agriculture and the environmental sciences, such as
B. fungorum, B. glumae, and B. plantarii. Given their degener-
ate design, however, it is unlikely that these primers are spe-
cific only for Burkholderia species; further testing of a broader
range of related genera is required in this regard. MLST anal-
ysis of B. mallei and B. pseudomallei may also be performed by
using a previously described scheme that includes two of the
seven target genes (gltB and lepA) in the B. cepacia complex
MLST scheme (5).
We included in our analysis four Burkholderia strains that
previous analyses, including recA and 16S rRNA gene sequenc-
ing, indicated were members of the B. cepacia complex but
could not be placed into any of the 17 named species in this
group. MLST analysis of these strains (AU0141, AU7004,
BC0021, and AU3207; Fig. 1) supports their taxonomic posi-
tion within the B. cepacia complex and their status as being
currently unclassified with respect to species. We also included
four strains (AU9801, AU15822, AU12613, and AU13858; Fig.
1) that were recovered from patient specimens and previously
identified to the Burkholderia genus level by 16S rRNA-di-
rected PCR analyses (6). MLST analysis of strains AU9801,
AU15822, AU12613, and AU13858 provided tentative assign-
ment as Burkholderia plantarii, B. tropica, B. fungorum, and B.
caledonica, respectively. These species are rarely recovered
from infected humans, and all were initially misidentified by
commercial phenotype-based identification systems. The anal-
ysis of clinical isolates representing potentially novel B. cepacia
complex species and Burkholderia species that are rarely en-
TABLE 1. Oligonucleotide primer sequences and annealing
temperatures for the amplification and sequencing of
seven MLST loci for Burkholderia species
Gene Ampliconsize (bp) Primer sequence (533)
Annealing
temp (°C)
atpD 756 ATGAGTACTRCTGCTTTGGTAG
AAGG
56
CGTGAAACGGTAGATGTT
GTCG
gltB 652 CTGCATCATGATGCGCAAGTG 58
CTTGCCGCGGAARTCGTTGG
gyrB 738 ACCGGTCTGCAYCACCTCGT 60
YTCGTTGWARCTGTCGTTCCA
CTGC
lepA 975 CTSATCATCGAYTCSTGGTTCG 55
CGRTATTCCTTGAACTCGTA
RTCC
phaC 525 GCACSAGYATYTGCCAGCG 58
CCATSTCSGTRCCRATGTAGCC
recA 704 AGGACGATTCATGGAAGA
WAGC
58
GACGCACYGAYGMRTAGA
ACTT
trpB 787 CGCGYTTCGGVATGGARTG 58
ACSGTRTGCATGTCCTTGTCG
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countered from human specimens highlights the utility and
expanded capacity of the revised MLST scheme.
Finally, our study also revealed a potential limitation to the
Burkholderia MLST scheme that has not been described in
previous studies. Amplification and sequence analysis of the
phaC locus in Burkholderia sp. strain H160 suggested the pres-
ence of two copies of this gene. In silico analysis of the draft
genome sequence of this strain (currently being sequenced by
the Joint Genome Institute [http://genome.jgi-psf.org]) con-
firmed the presence of two phaC homologues with 83% se-
quence identity, one on each of the two replicons of this ge-
nome. The presence of multiple copies, which may not be
100% identical, of any MLST locus confounds the interpreta-
tion of results and could limit the utility of this method for
epidemiologic and population genetic studies. This finding also
highlights a limitation of applying MLST analysis to genetically
plastic bacterial species in which large-scale genetic rearrange-
ments, which may or may not be apparent by MLST, are
FIG. 1. Phylogenetic tree of concatenated nucleotide sequences from the seven MLST loci, generated by using Clustal V. Burkholderia strains
included are representatives of the strain set analyzed as part of this study (see supplemental material) or strains for which genome sequence data
were available in public databases (indicated by ‡ symbol). Burkholderia strains in bold type are discussed in the text. Strains belonging to various
Burkholderia species and Burkholderia sp. strains are shown.
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possible. Depending on the questions being addressed, other
genotyping methods that provide a more comprehensive as-
sessment of the whole bacterial genome may complement
MLST analysis.
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